International
Prime Minister Trudeau heads to NATO summit, where leaders face critical decisions
Prime Minister Justin Trudeau departs Ottawa on Sunday, June 25, 2023, en route to Iceland. Trudeau is heading to the NATO leaders’ summit in Lithuania this week, where Canada is likely to play a larger-than-usual role in two critical discussions: the alliance’s expanding membership and its efforts to refocus on collective defence. THE CANADIAN PRESS/Sean Kilpatrick
By Sarah Ritchie in Ottawa
Prime Minister Justin Trudeau is heading to the NATO leaders’ summit in Lithuania this week, where Canada is likely to play a larger-than-usual role in two critical discussions: the alliance’s expanding membership and its efforts to refocus on collective defence.
Trudeau is expected to depart for Riga, Latvia, from Ottawa on Sunday evening. He is due to meet with that country’s leaders on Monday before heading to the Lithuanian capital for the first day of the NATO summit on Tuesday.
At last year’s summit in Madrid, NATO leaders identified Russia as “the most significant and direct threat to allies’ security and to peace and stability in the Euro-Atlantic area” in a strategic concept document that set out their intent to strengthen deterrence and defence in the region.
That came after a meeting in Brussels in March 2022, when leaders agreed to deploy four new multinational battle groups on the eastern flank in Bulgaria, Hungary, Romania and Slovakia, adding to those in Estonia, Latvia, Lithuania and Poland.
The alliance has drafted a new defence plan that leaders will be asked to approve in Vilnius, one that is being described as a return to its Cold War stance.
“What we’re seeing now is really a return to NATO’s core business,” said Tim Sayle, a NATO historian and professor at the University of Toronto.
He said this likely also means a return to more challenging negotiations among members as they decide on defence policy and procurement, at the same time as they are debating whether to allow Sweden and Ukraine to join. And on both topics, he said, allies will be looking to Canada.
“Rarely are there summits where Canada would be a focus of any elements, but I do think (it) is here,” Sayle said.
“Canada has a decision to make about its role in the discussion about Ukraine, but it also has this decision to make about Canadian defence spending and just what kind of ally Canada is going to be.”
Adm. Rob Bauer, the chair of NATO’s military committee, told media at a July 3 briefing that the new defence plan is split into three parts: the southeast region including the Mediterranean and the Black Sea, the central region from the Baltics to the Alps and the High North and Atlantic region.
Once the plans are approved, the real work begins. “Then we have to go and do our work to reach the higher number of forces with a higher readiness, we need to exercise against the plans, we need to buy the capabilities that we require,” Bauer said.
That will require more money. Only about a third of NATO members are meeting the agreed-upon target of spending two per cent of their GDP on defence — which includes a pledge to dedicate one-fifth of that funding to equipment.
Bauer said he expects two per cent will be the spending floor, instead of the target, by the time the summit is over.
“There is perhaps a stronger link than ever before between the new defence plans, the new defence investment pledge and the NATO defence planning process,” NATO spokesperson Oana Lungescu said at the July 3 briefing.
For the countries that are lagging behind, there will be increasing pressure to step up.
Canada spends about 1.3 per cent of its GDP on defence and has no public plan to get to the current target. Defence Minister Anita Anand has insisted that Canada’s contributions to the defence of Ukraine and its leadership in heading up a NATO battle group in Latvia are more important.
Before attending the NATO summit, Trudeau is set to participate in meetings Monday with Latvia’s president, Edgars Rinkēvičs, and its prime minister, Krišjānis Kariņš.
Trudeau is also expected to meet Canadian Armed Forces members who are part of the country’s largest overseas mission.
But even in Latvia, Canada seems to be lagging behind. It’s been more than a year since Anand pledged to expand the battle group to a combat-ready brigade, and detailed plans are still being negotiated. Battle groups typically have close to 1,000 troops, while military members in a brigade number about 3,000.
Canada has committed to sending a tank squadron with 15 Leopard 2 tanks and some 130 personnel to Latvia starting this fall, but it is unclear how many more troops will join the 800 Canadians already in place.
Other countries have gone further. Germany has pledged to station a 4,000-soldier brigade in Lithuania. The United Kingdom, which is leading a battle group in Estonia, and the United States, which leads another in Poland, tested their ability to quickly scale up to a brigade earlier this spring.
Leaders in Vilnius are also likely to focus on the status of Sweden and Ukraine, each of which has asked to join NATO.
Last-minute talks aimed at getting Turkiye and Hungary on side with allowing Sweden to become a member have not been successful. Its Nordic neighbour Finland joined most recently, in April.
If Sweden’s membership is approved, Bauer said it won’t take long to adapt the defence plans.
“Sweden is at the table in the military committee, in the North Atlantic Council every week. So they know basically everything already,” he said.
More contentious than that is the issue of when to admit Ukraine.
Some nations are pushing for immediate membership. U.K. Defence Secretary Ben Wallace said last month that he hopes to see an expedited process.
Meanwhile, Trudeau has repeatedly stated that Canada supports Ukraine’s membership “when the conditions are right,” without defining what those conditions are.
Sayle said it’s likely that other countries will expect a clearer response this time given the magnitude of the decision: whether to admit a nation that is in the midst of an active invasion to an alliance focused on collective defence.
“I think that what NATO says about Ukrainian membership will impact both the Ukrainian and Russian strategic calculations in this war, and any peace that might follow,” Sayle said.
This report by The Canadian Press was first published July 9, 2023.
Brownstone Institute
The WHO’s Proposed Pandemic Agreements Worsen Public Health
From the Brownstone Institute
BY
The WHO decided that the response for a Toronto aged care resident and a young mother in a Malawian village should be essentially the same – stop them from meeting family and working, then inject them with the same patented chemicals.
Much has been written on the current proposals putting the World Health Organization (WHO) front and center of future pandemic responses. With billions of dollars in careers, salaries, and research funding on the table, it is difficult for many to be objective. However, there are fundamentals here that everyone with public health training should agree upon. Most others, if they take time to consider, would also agree. Including, when divorced from party politicking and soundbites, most politicians.
So here, from an orthodox public health standpoint, are some problems with the proposals on pandemics to be voted on at the World Health Assembly at the end of this month.
Unfounded Messaging on Urgency
The Pandemic Agreement (treaty) and IHR amendments have been promoted based on claims of a rapidly increasing risk of pandemics. In fact, they pose an ‘existential threat’ (i.e. one that may end our existence) according to the G20’s High Level Independent Panel in 2022. However, the increase in reported natural outbreaks on which the WHO, the World Bank, G20, and others based these claims is shown to be unfounded in a recent analysis from the UK’s University of Leeds. The main database on which most outbreak analyses rely, the GIDEON database, shows a reduction in natural outbreaks and resultant mortality over the past 10 to 15 years, with the prior increase between 1960 and 2000 fully consistent with the development of the technologies necessary to detect and record such outbreaks; PCR, antigen and serology tests, and genetic sequencing.
The WHO does not refute this but simply ignores it. Nipah viruses, for example, only ‘emerged’ in the late 1990s when we found ways to actually detect them. Now we can readily distinguish new variants of coronavirus to promote uptake of pharmaceuticals. The risk does not change by detecting them; we just change the ability to notice them. We also have the ability to modify viruses to make them worse – this is a relatively new problem. But do we really want an organization influenced by China, with North Korea on its executive board (insert your favorite geopolitical rivals), to manage a future bioweapons emergency?
Irrespective of growing evidence that Covid-19 was not a natural phenomenon, modelling that the World Bank quotes as suggesting a 3x increase in outbreaks over the next decade actually predicts that a Covid-like event will recur less than once per century. Diseases that the WHO uses to suggest an increase in outbreaks over the past 20 years, including cholera, plague, yellow fever, and influenza variants were orders of magnitude worse in past centuries.
This all makes it doubly confusing that the WHO is breaking its own legal requirements in order to push through a vote without Member States having time to properly review implications of the proposals. The urgency must be for reasons other than public health need. Others can speculate why, but we are all human and all have egos to protect, even when preparing legally binding international agreements.
Low Relative Burden
The burden (e.g. death rate or life years lost) of acute outbreaks is a fraction of the overall disease burden, far lower than many endemic infectious diseases such as malaria, HIV, and tuberculosis, and a rising burden of non-communicable disease. Few natural outbreaks over the past 20 years have resulted in more than 1,000 deaths – or 8 hours of tuberculosis mortality. Higher-burden diseases should dominate public health priorities, however dull or unprofitable they may seem.
With the development of modern antibiotics, major outbreaks from the big scourges of the past like Plague and typhus ceased to occur. Though influenza is caused by a virus, most deaths are also due to secondary bacterial infections. Hence, we have not seen a repeat of the Spanish flu in over a century. We are better at healthcare than we used to be and have improved nutrition (generally) and sanitation. Widespread travel has eliminated the risks of large immunologically naive populations, making our species more immunologically resilient. Cancer and heart disease may be increasing, but infectious diseases overall are declining. So where should we focus?
Lack of Evidence Base
Investment in public health requires both evidence (or high likelihood) that the investment will improve outcomes and an absence of significant harm. The WHO has demonstrated neither with their proposed interventions. Neither has anyone else. The lockdown and mass vaccination strategy promoted for Covid-19 resulted in a disease that predominantly affects elderly sick people leading to 15 million excess deaths, even increasing mortality in young adults. In past acute respiratory outbreaks, things got better after one or perhaps two seasons, but with Covid-19 excess mortality persisted.
Within public health, this would normally mean we check whether the response caused the problem. Especially if it’s a new type of response, and if past understanding of disease management predicted that it would. This is more reliable than pretending that past knowledge did not exist. So again, the WHO (and other public-private partnerships) are not following orthodox public health, but something quite different.
Centralization for a Highly Heterogeneous Problem
Twenty-five years ago, before private investors became so interested in public health, it was accepted that decentralization was sensible. Providing local control to communities that could then prioritize and tailor health interventions themselves can provide better outcomes. Covid-19 underlined the importance of this, showing how uneven the impact of an outbreak is, determined by population age, density, health status, and many other factors. To paraphrase the WHO, ‘Most people are safe, even when some are not.’
However, for reasons that remain unclear to many, the WHO decided that the response for a Toronto aged care resident and a young mother in a Malawian village should be essentially the same – stop them from meeting family and working, then inject them with the same patented chemicals. The WHO’s private sponsors, and even the two largest donor countries with their strong pharmaceutical sectors, agreed with this approach. So too did the people paid to implement it. It was really only history, common sense, and public health ethics that stood in the way, and they proved much more malleable.
Absence of Prevention Strategies Through Host Resilience
The WHO IHR amendments and Pandemic Agreement are all about detection, lockdowns, and mass vaccination. This would be good if we had nothing else. Fortunately, we do. Sanitation, better nutrition, antibiotics, and better housing halted the great scourges of the past. An article in the journal Nature in 2023 suggested that just getting vitamin D at the right level may have cut Covid-19 mortality by a third. We already knew this and can speculate on why it became controversial. It’s really basic immunology.
Nonetheless, nowhere within the proposed US$30+ billion annual budget is any genuine community and individual resilience supported. Imagine putting a few billion more into nutrition and sanitation. Not only would you dramatically reduce mortality from occasional outbreaks, but more common infectious diseases, and metabolic diseases such as diabetes and obesity, would also go down. This would actually reduce the need for pharmaceuticals. Imagine a pharmaceutical company, or investor, promoting that. It would be great for public health, but a suicidal business approach.
Conflicts of Interest
All of which brings us, obviously, to conflicts of interest. The WHO, when formed, was essentially funded by countries through a core budget, to address high-burden diseases on country request. Now, with 80% of its use of funds specified directly by the funder, its approach is different. If that Malawian village could stump up tens of millions for a program, they would get what they ask for. But they don’t have that money; Western countries, Pharma, and software moguls do.
Most people on earth would grasp that concept far better than a public health workforce heavily incentivized to think otherwise. This is why the World Health Assembly exists and has the ability to steer the WHO in directions that don’t harm their populations. In its former incarnation, the WHO considered conflict of interest to be a bad thing. Now, it works with its private and corporate sponsors, within the limits set by its Member States, to mold the world to their liking.
The Question Before Member States
To summarize, while it’s sensible to prepare for outbreaks and pandemics, it’s even more sensible to improve health. This involves directing resources to where the problems are and using them in a way that does more good than harm. When people’s salaries and careers become dependent on changing reality, reality gets warped. The new pandemic proposals are very warped. They are a business strategy, not a public health strategy. It is the business of wealth concentration and colonialism – as old as humanity itself.
The only real question is whether the majority of the Member States of the World Health Assembly, in their voting later this month, wish to promote a lucrative but rather amoral business strategy, or the interests of their people.
espionage
The Scientists Who Came in From the Cold: Canada’s National Microbiology Laboratory Scandal, Part I
From the C2C Journal
By Peter Shawn Taylor
In a breathless 1999 article on the opening of Canada’s top-security National Microbiology Laboratory (NML) in Winnipeg, the Canadian Medical Association Journal described the facility as “the place where science fiction movies would be shot.” The writer was fascinated by the various containment devices and security measures designed to keep “the bad boys from the world of virology: Ebola, Marburg, Lassa” from escaping. But what if insiders could easily evade all those sci-fi features in order to help Canada’s enemies? In the first of a two-part series, Peter Shawn Taylor looks into the trove of newly-unclassified evidence regarding the role of NML scientists Xiangguo Qiu and Keding Cheng in aiding China’s expanding quest for the study – and potential military use – of those virus bad boys.
-
Brownstone Institute8 hours ago
Medical Elites’ Disgrace Over Ivermectin
-
National6 hours ago
Despite claims of 215 ‘unmarked graves,’ no bodies have been found at Canadian residential school
-
Brownstone Institute40 mins ago
The WHO’s Proposed Pandemic Agreements Worsen Public Health
-
COVID-192 hours ago
The New York Times Admits Injuries from COVID-19 Shots
-
Automotive13 hours ago
Electric vehicle mandates mean misery all around
-
Energy5 hours ago
Federal government continues to reject golden opportunities to export LNG
-
Opinion12 hours ago
The American Experiment Has Gone Down In Flames
-
Energy2 days ago
Pope Francis calls for ‘global financial charter’ at Vatican climate change conference